Comparative hazard identification by a single dose lung exposure of zinc oxide and silver nanomaterials in mice

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Gosens, Ilse ^a   Kermanizadeh, Ali ^b,g   Jacobsen, Nicklas Raun ^c   Lenz, Anke Gabriele ^d   Bokkers, Bas ^a   De Jong, Wim H ^a   Krystek, Petra ^e   Tran, Lang ^f   Stone, Vicki ^b   Wallin, Håkan ^c,g   Stoeger, Tobias ^d   Cassee, Flemming R ^a,h  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b HERIOT WATT UNIVERSITY   (United Kingdom)

^c NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e PHILIPS RESEARCH LABORATORIES   (Germany)

^f IOM   (United Kingdom)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

^h UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; LACTATE DEHYDROGENASE; PROTEIN; SILANE DERIVATIVE; SILVER; SILVER NANOPARTICLE; TRIETHOXYCAPRYLYLSILANE; UNCLASSIFIED DRUG; WATER; ZINC OXIDE; NANOMATERIAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; C57BL/6N MOUSE; CELL DAMAGE; COMPARATIVE HAZARD IDENTIFICATION; CONTROLLED STUDY; CYTOTOXICITY; EXPOSURE; FEMALE; HAZARD ASSESSMENT; INFLAMMATION; LIVER; LUNG; LUNG LAVAGE; LYMPHOCYTE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; STATISTICAL MODEL; TOXICITY TESTING; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; DRUG INSTILLATION; INTRASPINAL DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; PROCEDURES;

MUS;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; INJECTIONS, SPINAL; INSTILLATION, DRUG; LUNG; MICE; MICE, INBRED C57BL; NANOSTRUCTURES; SILVER; TOXICITY TESTS; ZINC OXIDE;

EID: 84930678084     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126934     Document Type: Article

References (54)

1. Nel A, XiaT, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311(5761):622-7. PMID: 16456071
2. Klein CL, ComeroS, Stahlmecke D, Romazanov J, KuhlbuschT A J, Van Doren E, et al. NM-Seriesof Representative Manufactured Nanomaterials: NM-300 Silver Characterisation, Stability, Homogeneity. Joint Research Centre, 2011.
3. WPMN. Guidance Manual forthe Testing of Manufactured Nanomaterials: OECD's Sponsorship Programme (1st Revision: June 2010). OECD WPMN Publication Series, No. 25, 2010.
4. Kermanizadeh A, PojanaG, Gaiser BK, Birkedal R, Bilanicova D, Wallin H, et al. In vitro assessment of engineered nanomaterials using a hepatocyte cell line: cytotoxicity, pro-inflammatory cytokines and functional markers. Nanotoxicology. 2013;7:301-13. doi: 10.3109/17435390.2011.653416 PMID: 22263564
5. Kermanizadeh A, Vranic S, Boland S, Moreau K, Baeza-Squiban A, Gaiser BK, et al. An in vitro assessment of panel of engineered nanomaterials using a human renal cell line: cytotoxicity, pro-inflammatory response, oxidative stress and genotoxicity. BMC nephrology. 2013;14:96. doi: 10.1186/1471-2369-14-96 PMID: 23617532
6. KreylingWG, SemmlerM, Erbe F, Mayer P, Takenaka S, Schulz H, et al. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A. 2002;65(20):1513-30. PMID: 12396866
7. Landsiedel R, Fabian E, Ma-Hock L, Wohlleben W, Wiench K, Oesch F, et al. Toxico-/biokinetics of nanomaterials. Arch Toxicol. 2012;86(7):1021-60. doi: 10.1007/s00204-012-0858-7 PMID: 22576463
8. Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, et al. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect. 2001;109 Suppl 4:547-51. PMID: 11544161
9. Nemmar A, Vanbilloen H, Hoylaerts MF, Hoet PH, Verbruggen A, Nemery B. Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. AmJRespirCritCare Med. 2001;164(9):1665-8. PMID: 11719307
10. OberdorsterG, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, et al. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A. 2002;65(20):1531-43. PMID: 12396867
11. Sadauskas E, Jacobsen NR, DanscherG, Stoltenberg M, Vogel U, Larsen A, et al. Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation. ChemCentJ. 2009;3:16.
12. Semmler-Behnke M, KreylingWG, Lipka J, Fertsch S, WenkA, Takenaka S, et al. Biodistribution of 1.4- and 18-nmgold particles in rats. Small. 2008;4(12):2108-11. doi: 10.1002/smll.200800922 PMID: 19031432
13. Jacobsen NR, PojanaG, White P, Moller P, CohnCA, Korsholm KS, et al. Genotoxicity, cytotoxicity, and reactive oxygen species induced by single-walled carbon nanotubes and C (60) fullerenes in the FE1-MutatrademarkMouse lung epithelial cells. Environ Mol Mutagen. 2008;49(6):476-87. doi: 10. 1002/em.20406 PMID: 18618583
14. Moller P, Jacobsen NR, Folkmann JK, Danielsen PH, Mikkelsen L, Hemmingsen JG, et al. Role of oxidative damage in toxicity of particulates. Free radical research. 2010;44(1):1-46. doi: 10.3109/10715760903300691 PMID: 19886744
15. Stone V, Shaw J, Brown DM, Macnee W, FauxSP, Donaldson K. The role of oxidative stress in the prolonged inhibitory effect of ultrafine carbon black on epithelial cell function. Toxicol In Vitro. 1998;12(6):649-59. PMID: 20654455
16. Wilson MR, Lightbody JH, Donaldson K, Sales J, Stone V. Interactions between ultrafine particles and transition metals in vivo and in vitro. Toxicol Appl Pharmacol. 2002;184(3):172-9. PMID: 12460745
17. Foucaud L, Wilson MR, Brown DM, Stone V. Measurement of reactive species production by nanoparticles prepared in biologically relevant media. Toxicol Lett. 2007;174(1-3):1-9. PMID: 17945439
18. XiaT, Li N, Nel AE. Potential health impact of nanoparticles. Annual Review of Public Health. 2009;30:137-50. doi: 10.1146/annurev. publhealth.031308.100155 PMID: 19705557
19. Diesen DL, Kuo PC. Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitis. The Journal of surgical research. 2010;162(1):95-109. doi: 10.1016/j.jss. 2009.09.019 PMID: 20444470
20. Henderson RF, Driscoll KE, Harkema JR, Lindenschmidt RC, Chang IY, Maples KR, et al. A comparison of the inflammatory response of the lung to inhaled versus instilled particles in F344 rats. FundamApplToxicol. 1995;24(2):183-97.
21. Bosgra S, Van Der Voet H, Boon PE, Slob W. An integrated probabilistic framework for cumulative risk assessment of common mechanism chemicals in food: an example with organophosphorus pesticides. Regul Toxicol Pharmacol. 2009;54(2):124-33. doi: 10.1016/j.yrtph.2009.03.004 PMID: 19303907
22. Slob W, Setzer RW. Shape and steepness of toxicological dose-response relationships of continuous endpoints. Crit Rev Toxicol. 2014;44(3):270-97. doi: 10.3109/10408444.2013.853726 PMID: 24252121
23. Jacobsen NR, Moller P, Jensen KA, Vogel U, LadefogedO, LoftS, et al. Lung inflammation andgenotoxicity following pulmonary exposure to nanoparticles in ApoE-/-mice. Particle and fibre toxicology. 2009;6 (2). doi: 10.1186/1743-8977-6-2 PMID: 19138394
24. Bonner JC, Silva RM, Taylor AJ, Brown JM, Hilderbrand SC, Castranova V, et al. Interlaboratory Evaluation of Rodent Pulmonary Responses to Engineered Nanomaterials: The NIEHS Nano GO Consortium. Environmental Health Perspectives. 2013;121(6):676-82. doi: 10.1289/ehp. 1205693 PMID: 23649427
25. Saber AT, Lamson JS, Jacobsen NR, Ravn-Haren G, Hougaard KS, Nyendi AN, et al. Particle-induced pulmonary acute phase response correlates with neutrophil influx linking inhaled particles and cardiovascular risk. PLoSOne. 2013;8(7):e69020. doi: 10.1371/journal.pone.0069020 PMID: 23894396
26. SenftAP, DaltonTP, ShertzerHG. Determining glutathione and glutathione disulfide using the fluorescence probe o-phthalaldehyde. Anal Biochem. 2000;280(1):80-6. PMID: 10805524
27. Crump KS. A new method for determining allowable daily intakes. Fundam Appl Toxicol. 1984;4(5):854-71. PMID: 6510615
28. SlobW. Dose-response modeling of continuous endpoints. Toxicol Sci. 2002;66(2):298-312. PMID: 11896297
29. EFSA. Guidance of the Scientific Committee on a request from EFSA on the use of the benchmark dose approach in risk assessment. EFSA Journal. 2009;1150:1-72.
30. Cho WS, Duffin R, Poland CA, Howie SE, MacNee W, Bradley M, et al. Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ Health Perspect. 2010;118(12):1699-706. doi: 10.1289/ehp. 1002201 PMID: 20729176
31. Gordon T, Fine JM. Metal fume fever. OccupMed. 1993;8(3):504-17. PMID: 8272976
32. Kuschner WG, D'Alessandro A, Wong H, Blanc PD. Early pulmonary cytokine responses to zinc oxide fume inhalation. Environ Res. 1997;75(1):7-11. PMID: 9356189
33. Fine JM, Gordon T, Chen LC, Kinney P, Falcone G, Beckett WS. Metal fume fever: characterization of clinical and plasma IL-6 responses in controlled human exposures to zinc oxide fume at and below the threshold limit value. J Occup Environ Med. 1997;39(8):722-6. PMID: 9273875
34. Gordon T, Chen LC, Fine JM, SchlesingerRB, Su WY, KimmelTA, et al. Pulmonary effects of inhaled zinc oxide in human subjects, guinea pigs, rats, and rabbits. Am Ind Hyg Assoc J. 1992;53(8):503-9. PMID: 1509990
35. Wesselkamper SC, Chen LC, Gordon T. Development of pulmonary tolerance in mice exposed to zinc oxide fumes. Toxicol Sci. 2001;60(1):144-51. PMID: 11222881
36. Hyun JS, Lee BS, Ryu HY, Sung JH, Chung KH, Yu IJ. Effects of repeated silver nanoparticles exposure on the histological structure and mucins of nasal respiratory mucosa in rats. Toxicol Lett. 2008;182(1-3):24-8. doi: 10.1016/j.toxlet.2008.08.019 PMID: 18835341
37. BezemerGF, Bauer SM, OberdorsterG, Breysse PN, Pieters RH, Georas SN, et al. Activation of pulmonary dendritic cells and Th2-type inflammatory responses on instillation of engineered, environmental diesel emission source or ambient air pollutant particles in vivo. Journal of innate immunity. 2011;3(2):150-66. doi: 10.1159/000321725 PMID: 21099199
38. Stebounova LV, Adamcakova-Dodd A, Kim JS, Park H, O'Shaughnessy PT, Grassian VH, et al. Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Part Fibre Toxicol. 2011;8(1):5. doi: 10.1186/1743-8977-8-5 PMID: 21266073
39. Liu H, Yang D, Yang H, Zhang H, Zhang W, Fang Y, et al. Comparative study of respiratory tract immune toxicity induced by three sterilisation nanoparticles: Silver, zinc oxide and titanium dioxide. Journal of Hazardous Materials. 2013;248-249C: 478-86. doi: 10.1016/j.jhazmat.2013.07.053 PMID: 23972665
40. Cho WS, Duffin R, Poland CA, Duschl A, Oostingh GJ, Macnee W, et al. Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotoxicology. 2012;6:22-35. doi: 10.3109/17435390.2011.552810 PMID: 21332300
41. Gilbert B, FakraSC, XiaT, Pokhrel S, Madler L, Nel AE. The Fate of ZnO Nanoparticles Administered to Human Bronchial Epithelial Cells. ACS nano. 2012;6(6):4921-30. doi: 10.1021/nn300425a PMID: 22646753
42. Vandebriel RJ, De Jong WH. A review of mammalian toxicity of ZnO nanoparticles. Nanotechnology, Science and Applications. 2012;6:61-71.
43. Wijnhoven SWP, Peijnenburg WJGM, Herberts CA, Hagens WI, Oomen AG, Heugens EHW, et al. Nano-silver-a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology. 2009;3(2):109-38.
44. EPA US. Zinc oxide; Toxic chemical release reporting; Community right- to know. 1995.
45. Osmond MJ, McCall MJ. Zinc oxide nanoparticles in modern sunscreens: an analysis of potential exposure and hazard. Nanotoxicology. 2010;4(1):15-41. doi: 10.3109/17435390903502028 PMID: 20795900
46. SCCS. Opinion on Zinc oxide (nano form) COLIPA S 76. Scientific Committee on Consumer Safety, 2012.
47. Cho WS, Duffin R, Howie SE, Scotton CJ, Wallace WA, Macnee W, et al. Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part Fibre Toxicol. 2011;8:27. doi: 10.1186/1743-8977-8-27 PMID: 21896169
48. Kermanizadeh A, Gaiser BK, Ward MB, Stone V. Primary human hepatocytes versus hepatic cell line: assessing their suitability for in vitro nanotoxicology. Nanotoxicology. 2013; Early online: 1-17.
49. Stebounova LV, Guio E, Grassian VH. Silver nanoparticles in simulated biological media: a study of aggregation, sedimentation, and dissolution. Journal of Nanoparticle Research. 2011;13:233-44.
50. Kermanizadeh A, Gaiser BK, Hutchison GR, Stone V. An in vitro liver model-assessing oxidative stress and genotoxicity following exposure of hepatocytes to a panel of engineered nanomaterials. Particle & Fibre Toxicology [Electronic Resource]. 2012;9:28.
51. Adeyemi OS, Faniyan TO. Antioxidant status of rats administered silver nanoparticles orally. Journal of Taibah University Medical Sciences. 2014:1-5.
52. Ebabe Elle R, GailletS, Vide J, RomainC, LauretC, Rugani N, et al. Dietary exposure to silver nanoparticles in Sprague-Dawley rats: effects on oxidative stress and inflammation. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association. 2013;60:297-301. doi: 10.1016/j.fct.2013.07.071 PMID: 23933361
53. Patlolla AK, Hackett D, Tchounwou PB. Oxidative Stress-Dependent Toxicity Induced by Silver Nanoparticle in Liver of Sprague-Dawley Rats. 13th International Symposium on Metal Ions in Biology & Medicine; Jackson, MS, USA2014.
54. Lenz A-G, Karg E, Brendel E, Hinze-Heyn H, MaierKL, EickelbergO, et al. Inflammatory and oxidative stress responses of an alveolar epithelial cell line to airborne zinc oxide nanoparticles at the air-liquid interface: a comparison with conventional, submerged cell-culture conditions. Biomed Res Int. 2013;2013:652632. doi: 10.1155/2013/652632 PMID: 23484138